TY - JOUR AU - Haar, J. AU - Hoes, L. R. AU - Coles, C. E. PY - 2020 DA - 2020// TI - Caring for patients with cancer in the COVID-19 era JO - Nat Med VL - 26 UR - https://doi.org/10.1038/s41591-020-0874-8 DO - 10.1038/s41591-020-0874-8 ID - Haar2020 ER - TY - JOUR AU - Desai, A. AU - Sachdeva, S. AU - Parekh, T. PY - 2020 DA - 2020// TI - COVID-19 and cancer: lessons from a pooled meta-analysis JO - JCO Glob Oncol VL - 6 UR - https://doi.org/10.1200/GO.20.00097 DO - 10.1200/GO.20.00097 ID - Desai2020 ER - TY - STD TI - Barlesi F, Foulon S, Bayle A, et al. Outcome of cancer patients infected with COVID-19, including toxicity of cancer treatments. In: AACR annual meeting I, April 27–28; 2020. ID - ref3 ER - TY - JOUR AU - Rugge, M. AU - Zorzi, M. AU - Guzzinati, S. PY - 2020 DA - 2020// TI - SARS-CoV-2 infection in the Italian Veneto region: adverse outcomes in patients with cancer JO - Nat Cancer VL - 8 UR - https://doi.org/10.1038/s43018-020-0104-9 DO - 10.1038/s43018-020-0104-9 ID - Rugge2020 ER - TY - JOUR AU - Liang, W. AU - Guan, W. AU - Chen, R. PY - 2020 DA - 2020// TI - Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China JO - Lancet Oncol VL - 21 UR - https://doi.org/10.1016/S1470-2045(20)30096-6 DO - 10.1016/S1470-2045(20)30096-6 ID - Liang2020 ER - TY - JOUR AU - Zhang, L. AU - Zhu, F. AU - Xie, L. PY - 2020 DA - 2020// TI - Clinical characteristics of COVID-19 infected cancer patients: a retrospective case study in three hospitals within Wuhan, China JO - Ann Oncol VL - 31 UR - https://doi.org/10.1016/j.annonc.2020.03.296 DO - 10.1016/j.annonc.2020.03.296 ID - Zhang2020 ER - TY - JOUR AU - Robilotti, E. V. AU - Babady, N. E. AU - Mead, P. A. PY - 2020 DA - 2020// TI - Determinants of COVID-19 disease severity in patients with cancer JO - Nat Med VL - 26 UR - https://doi.org/10.1038/s41591-020-0979-0 DO - 10.1038/s41591-020-0979-0 ID - Robilotti2020 ER - TY - JOUR AU - Garassino, M. C. AU - Whisenant, J. G. AU - Huang, L. C. PY - 2020 DA - 2020// TI - COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study JO - Lancet Oncol VL - 21 UR - https://doi.org/10.1016/S1470-2045(20)30314-4 DO - 10.1016/S1470-2045(20)30314-4 ID - Garassino2020 ER - TY - JOUR AU - Rutigliano, J. A. AU - Sharma, S. AU - Morris, M. Y. PY - 2020 DA - 2020// TI - Highly pathological influenza A virus infection is associated with augmented expression of PD-1 by functionally compromised virus-specific CD8+ T cells JO - J Virol VL - 88 UR - https://doi.org/10.1128/JVI.02851-13 DO - 10.1128/JVI.02851-13 ID - Rutigliano2020 ER - TY - JOUR AU - Ethun, C. G. AU - Bilen, M. A. AU - Jani, A. B. PY - 2017 DA - 2017// TI - Frailty and cancer: implications for oncology surgery, medical oncology, and radiation oncology JO - CA Cancer J Clin VL - 67 UR - https://doi.org/10.3322/caac.21406 DO - 10.3322/caac.21406 ID - Ethun2017 ER - TY - JOUR AU - Poortmans, P. M. AU - Guarneri, V. AU - Cardoso, M. -. J. PY - 2020 DA - 2020// TI - Cancer and COVID-19: what do we really know? JO - Lancet VL - 395 UR - https://doi.org/10.1016/S0140-6736(20)31240-X DO - 10.1016/S0140-6736(20)31240-X ID - Poortmans2020 ER - TY - JOUR AU - Vivarelli, S. AU - Falzone, L. AU - Grillo, C. M. PY - 2020 DA - 2020// TI - Cancer management during COVID-19 pandemic: is immune checkpoint inhibitors-based immunotherapy harmful or beneficial? JO - Cancers VL - 12 UR - https://doi.org/10.3390/cancers12082237 DO - 10.3390/cancers12082237 ID - Vivarelli2020 ER -